Multicentric hepatocellular carcinoma following phosphate diethylstilbestrol therapy for prostatic cancer

Acta Pathol Jpn. 1987 May;37(5):795-806. doi: 10.1111/j.1440-1827.1987.tb00413.x.

Abstract

This paper reports an autopsy case of a 78-year-old male with multiple nodules in the liver developed after long-termed administration of phosphate diethylstilbestrol (PDES) for prostatic cancer. Large part of these nodules were suspected to be well differentiated hepatocellular carcinoma with high level of serum alpha-fetoprotein (AFP) up to 3,400 ng/ml, but a part of them was evaluated to be a borderline between hepatocellular carcinoma and adenoma with mild cellular atypism. The liver other than the nodules showed liver fibrosis associated with liver cell dysplasia and peliosis hepatis-like change. This is a unique autopsy case of hepatocellular carcinoma closely related to diethylstilbestrol (DES) therapy for prostatic cancer.

Publication types

  • Case Reports

MeSH terms

  • Adenoma / pathology
  • Adenoma / secondary
  • Aged
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / secondary*
  • Diethylstilbestrol / adverse effects
  • Diethylstilbestrol / analogs & derivatives*
  • Diethylstilbestrol / therapeutic use
  • Humans
  • Liver / pathology
  • Liver Neoplasms / pathology
  • Liver Neoplasms / secondary*
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • alpha-Fetoproteins / analysis

Substances

  • alpha-Fetoproteins
  • diethylstilbestrol monophosphate
  • Diethylstilbestrol